ArticleCell death & disease2026
Vascular SMC-like CAF-derived THBS1 drives tumor-associated neutrophil recruitment to orchestrate an immunosuppressive microenvironment in gastric cancer.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The immunosuppressive tumor microenvironment (TME) remains a primary barrier to effective immunotherapy. Tumor-associated neutrophils (TANs) are key contributors to this immunosuppressive landscape; however, the mechanisms governing their recruitment and infiltration into tumor tissues remain poorly understood. In this study, we unravel a pro-tumorigenic role of thrombospondin-1 (THBS1) in gastric cancer (GC) mediated by TAN recruitment. By integrating single-cell RNA sequencing with immunohistochemical analyses, we demonstrated that THBS1 is predominantly expressed in vascular smooth muscle cell (VSMC)-like cancer-associated fibroblast (CAF), with lower expression observed in malignant epithelial cells. Notably, THBS1-expressing CAFs are significantly expanded in GC tissues. Accordingly, THBS1 is upregulated in GC, and its overexpression is clinically associated with malignant progression and poor prognosis. Genetic depletion of THBS1 in CAFs markedly suppressed GC progression both in vitro and in vivo. Furthermore, deconvolution analysis, patient-derived xenograft (PDX) models, and multiplex immunofluorescence (mIHC) revealed a pronounced spatial co-localization between THBS1-positive CAFs and TANs within GC tissues. TAN infiltration was significantly elevated in GC and positively correlated with THBS1 expression levels and adverse survival outcomes. Critically, neutralizing THBS1 with monoclonal antibodies or specifically knocking down THBS1 in CAFs dramatically reduced TAN infiltration in both PDX and nude mouse xenograft models. Mechanistically, THBS1 knockdown in CAFs impaired the autocrine production and secretion of key neutrophil-attracting chemokines, including CXCL1, CXCL5, and CXCL6. In summary, our findings underscore the significance of SMC-like CAF-derived THBS1 as a critical molecular mediator in the dynamic interplay between CAFs and TANs, ultimately driving GC progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.